MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CDTX has $518,650K in assets. $96,263K in debts. $293,651K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
462.05%
Cash Ratio
306.40%
Debt to Asset Ratio
18.56%
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments, availabl...
    • Long-term investments, available...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued liabilities
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
293,651 510,575
Restricted cash
6,337 6,338
Short-term investments, available-for-sale
126,370 -
Accounts receivable
1,861 1,859
Prepaid expenses and other current assets
14,602 13,019
Total current assets
442,821 531,791
Property and equipment, net
293 321
Finance lease right-of-use asset, net
0 0
Operating lease right-of-use asset
1,795 2,120
Long-term investments, available-for-sale
50,159 -
Other assets
23,582 95
Total assets
518,650 534,327
Accounts payable
4,351 2,206
Accrued liabilities
71,349 11,054
Accrued indirect tax liabilities
15,073 14,935
Accrued compensation and benefits
3,506 2,626
Current portion of finance lease liability
0 0
Current portion of operating lease liability
1,560 1,497
Total current liabilities
95,839 32,318
Long-term finance lease liability
0 0
Long-term operating lease liability
424 836
Total liabilities
96,263 33,154
Preferred stock
0 0
Preferred stock-Series AConvertible Voting Preferred Stock
0 0
Preferred stock-Series XConvertible Preferred Stock
0 0
Common stock, 0.0001 par value 100,000,000 shares authorized at september30, 2025 and 50,000,000 shares authorized at december31, 2024 29,335,397 shares issued and outstanding at september30, 2025 and 10,946,635 shares issued and outstanding at december31, 2024
3 2
Additional paid-in capital
1,166,180 1,161,627
Accumulated other comprehensive loss
-107 -
Accumulated deficit
-743,689 -660,456
Total stockholders equity
422,387 501,173
Total liabilities and stockholders equity
518,650 534,327
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$14,602K Accounts receivable$1,861K Short-term investments,available-for-sale$126,370K Restricted cash$6,337K Cash and cashequivalents$293,651K Other assets$23,582K Long-term investments,available-for-sale$50,159K Operating leaseright-of-use asset$1,795K Property and equipment,net$293K Total current assets$442,821K Total assets$518,650K Total liabilities andstockholders equity$518,650K Total stockholdersequity$422,387K Total liabilities$96,263K Accumulated deficit-$743,689K Accumulated othercomprehensive loss-$107K Additional paid-in capital$1,166,180K Long-term operating leaseliability$424K Total currentliabilities$95,839K Common stock, 0.0001par value...$3K Current portion ofoperating lease liability$1,560K Accrued compensationand benefits$3,506K Accrued indirect taxliabilities$15,073K Accrued liabilities$71,349K Accounts payable$4,351K

Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics, Inc. (CDTX)